Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of PELOID Therapy and Kinesio Tape Effectiveness in Patients With Lateral Epicondylitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04687943
Recruitment Status : Completed
First Posted : December 29, 2020
Last Update Posted : September 1, 2021
Sponsor:
Information provided by (Responsible Party):
Süleyman Gül, Konya Meram State Hospital

Brief Summary:
In this study, the difference in effectiveness between PELOID therapy and kinesio tape in the treatment of lateral epicondylitis; It was planned to evaluate the effects of these treatments on pain, functionality, activities of daily living and quality of life.

Condition or disease Intervention/treatment
Lateral Epicondylitis Patient Engagement Combination Product: PELOID therapy, kinesio tape, exercise

Show Show detailed description

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 3 participants
Observational Model: Case-Control
Time Perspective: Prospective
Target Follow-Up Duration: 1 Month
Official Title: Comparison of PELOID Therapy and Kinesio Tape Effectiveness in Patients With Lateral Epicondylitis
Actual Study Start Date : November 27, 2017
Actual Primary Completion Date : January 18, 2021
Actual Study Completion Date : May 1, 2021

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
PELOID therapy
A total of 15 sessions of peloid therapy for 3 weeks, 5 days a week for 42 patients in the first group
Combination Product: PELOID therapy, kinesio tape, exercise
126 patients diagnosed with lateral epicondylitis will be divided into 3 groups. Totally 15 sessions of peloid therapy for 42 patients in 1 group for 3 weeks, 5 days a week, 2 sessions of muscle and fascia correction techniques for 3 weeks in the second group for 3 weeks, and 3 sets per day for 42 patients in the third group for 3 weeks. You will be given 10 repetitive home workouts.

Kinesio tape
42 patients in group 2 will be given 2 sessions of muscle and fascia correction techniques per week, with kinesio tape application and cold application
Combination Product: PELOID therapy, kinesio tape, exercise
126 patients diagnosed with lateral epicondylitis will be divided into 3 groups. Totally 15 sessions of peloid therapy for 42 patients in 1 group for 3 weeks, 5 days a week, 2 sessions of muscle and fascia correction techniques for 3 weeks in the second group for 3 weeks, and 3 sets per day for 42 patients in the third group for 3 weeks. You will be given 10 repetitive home workouts.

Exercise
42 patients in the third group will be given 3 sets of 10 repetitions home exercise programs for 3 weeks
Combination Product: PELOID therapy, kinesio tape, exercise
126 patients diagnosed with lateral epicondylitis will be divided into 3 groups. Totally 15 sessions of peloid therapy for 42 patients in 1 group for 3 weeks, 5 days a week, 2 sessions of muscle and fascia correction techniques for 3 weeks in the second group for 3 weeks, and 3 sets per day for 42 patients in the third group for 3 weeks. You will be given 10 repetitive home workouts.




Primary Outcome Measures :
  1. PELOID THERAPY AND KINESIO TAPE PROVIDES PAIN REDUCTION IN DAILY LIFE ACTIVITIES OF PATIENTS [ Time Frame: November 2017-January 2021 ]
    Significant reduction in VAS pain severity scale is expected in patients with PELOID therapy and kinesio tape application.

  2. PELOID THERAPY AND KINESIO TAPE INCREASES PATIENT'S HAND GRIP [ Time Frame: November 2017-January 2021 ]
    After both treatments, there was a significant increase in grip strength evaluated by Jamar dynamometer.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
126 patients between the ages of 18-65 were included in the study according to the inclusion and exclusion criteria.
Criteria

Inclusion Criteria:

  • The patient has pain in the lateral elbow
  • Tenderness over the lateral epicondyle
  • Pain for at least 3 months with resistant wrist extension
  • Between the ages of 18-65

Exclusion Criteria:

  • Under the age of 18 or over 65
  • Those with communication problems
  • Those with a history of injection, surgery, or physical therapy for Lateral epicondylitis within the last 1 year
  • Those with a history of cervical and shoulder problems, a history of polyneuropathy, a history of uncontrollable systemic disease (cardiovascular, pulmonary, hepatic, renal, hematologic), those with a history of systemic endocrine disease (DM, Hyperthyroidism)
  • Major psychiatric diseases
  • Rheumatic diseases such as fibromyalgia, polymyalgia rheumatica, ankylosing spondylitis, rheumatoid arthritis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04687943


Locations
Layout table for location information
Turkey
Konya City Hospital
Konya, Turkey
Sponsors and Collaborators
Konya Meram State Hospital
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Süleyman Gül, medical doctor, Konya Meram State Hospital
ClinicalTrials.gov Identifier: NCT04687943    
Other Study ID Numbers: KonyaFizikTedaviYazır
First Posted: December 29, 2020    Key Record Dates
Last Update Posted: September 1, 2021
Last Verified: August 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Tennis Elbow
Elbow Tendinopathy
Tendinopathy
Muscular Diseases
Musculoskeletal Diseases
Arm Injuries
Wounds and Injuries
Tendon Injuries